Can risk-adapted treatment recommendations replace the 'one size fits all' approach for early-stage thyroid cancer patients?
- PMID: 19626825
Can risk-adapted treatment recommendations replace the 'one size fits all' approach for early-stage thyroid cancer patients?
Comment on
-
What is the optimal initial treatment of low-risk papillary thyroid cancer (and why is it controversial)?Oncology (Williston Park). 2009 Jun;23(7):579-88. Oncology (Williston Park). 2009. PMID: 19626823 Review.
Publication types
MeSH terms
LinkOut - more resources
Medical